Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 25, 2008 20:00 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon Presents Phase 1 Clinical Trial Results for LX2931 At American College of Rheumatology Annual Meeting

* New Small Molecule Drug Candidate for Rheumatoid Arthritis and Other Autoimmune Diseases * Novel Mechanism of Action of Immune Modulation Shows Activity in Human Studies *...
October 16, 2008 16:00 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon to Report Third Quarter 2008 Financial Results On October 30, 2008

THE WOODLANDS, Texas, Oct. 16, 2008 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) will release its third quarter 2008 financial results on Thursday, October 30, 2008 before the...
October 14, 2008 16:00 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon to Present Clinical Data for LX2931, an Investigational New Drug for Rheumatoid Arthritis

THE WOODLANDS, Texas, Oct. 14, 2008 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human...
August 13, 2008 06:30 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals Identifies New Drug Candidate for Glaucoma

* Novel Target for Regulating Intraocular Pressure in the Eye * Currently No Marketed Drugs Targeting LX7101 Mechanism of Action * Glaucoma Affects 4 Million Americans, 65 Million...
July 29, 2008 06:30 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals' Drug Candidate for Irritable Bowel Syndrome Completes Phase 1 Clinical Trial Showing Positive Results

THE WOODLANDS, Texas, July 29, 2008 (PRIME NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human...
July 29, 2008 06:30 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals Reports 2008 Second Quarter Financial Results

Five Clinical Programs Anticipated by Year-End Conference Call and Webcast At 11:00 a.m. Eastern Time THE WOODLANDS, Texas, July 29, 2008 (PRIME NEWSWIRE) -- Lexicon...
July 17, 2008 16:00 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon to Report Second Quarter 2008 Financial Results On July 29, 2008

THE WOODLANDS, Texas, July 17, 2008 (PRIME NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) will release its second quarter 2008 financial results on Tuesday, July 29, 2008 before the...
June 03, 2008 06:30 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA

THE WOODLANDS, Texas, June 3, 2008 (PRIME NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human...
May 28, 2008 06:30 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals Implements Reorganization to Deploy Resources Toward Drug Development Pipeline

THE WOODLANDS, Texas, May 28, 2008 (PRIME NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) announced today that it is implementing a reorganization designed to reduce costs and increase...
May 08, 2008 16:00 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals to Present At the Bank of America Health Care Conference

THE WOODLANDS, Texas, May 8, 2008 (PRIME NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) announced today that a member of Lexicon senior management will present at the Bank of America Health...